| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
| mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
-0.011 |
0.9 |
| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0022 |
1 |
| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
-0.0029 |
1 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.0026 |
1 |
| mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
0.0096 |
1 |
| mRNA |
AZD-7545 |
CTRPv2 |
pan-cancer |
AAC |
-0.0019 |
1 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
1 |
| mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0017 |
1 |
| mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.0017 |
1 |